Prudential Financial
AVEO

Prudential Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Prudential Financial’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,436
Closed -$111K – 2326
2013
Q2 		$111K Buy
+4,436
New +$190K ﹤0.01% 2213

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prudential Financial's AVEO Position: Q3 2013 in Review

Prudential Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2013, closing a stake of 4,436 shares — an estimated $111K sold.

Prudential Financial first reported a position in AVEO in Q2 2013 and held it in 1 quarter. The position peaked at $111K in Q2 2013. 81 funds tracked by Wall St. Rank hold AVEO as of Q3 2013.

  • Prudential Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Prudential Financial sold 4,436 AVEO Pharmaceuticals, Inc. shares in Q3 2013, an estimated $111K.
  • Prudential Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Prudential Financial's AVEO Pharmaceuticals, Inc. position peaked at $111K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2013.

Based on Prudential Financial's 13F filing for Q3 2013, filed 7 Nov 2013.